We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
-12.19%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$208M
AUM Growth
+$9.47M
Cap. Flow
+$34.9M
Cap. Flow %
16.75%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
2
Reduced
1
Closed
1

Top Sells

Rank Stock Value
1
CIT
CIT Group Inc.
CIT
+$10.6M
2
MGLN
Magellan Health Services, Inc.
MGLN
+$8.52M

Sector Composition

Rank Sector Weight
1 Healthcare 61.52%
2 Financials 21.18%
3 Industrials 17.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$51.9M 24.9%
971,000
CIT
2
DELISTED
CIT Group Inc.
CIT
$41.9M 20.13%
851,557
-219,300
-20% -$10.6M
ATRC icon
3
AtriCure
ATRC
$1.7B
$36.6M 17.56%
2,005,610
+150,610
+8% +$2.98M
CATM
4
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$36M 17.3%
+1,945,655
New +$38.9M
ACOR
5
DELISTED
Acorda Therapeutics
ACOR
$28.2M 13.56%
10,973
+3,527
+47% +$10M
CVRS
6
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$11.4M 5.5%
11,336,154
FCB
7
DELISTED
FCB Financial Holdings, Inc.
FCB
$2.18M 1.05%
+43,000
New +$2.11M
MGLN
8
DELISTED
Magellan Health Services, Inc.
MGLN
-98,700
Closed -$8.52M

Similar funds

Hudson Executive Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Hudson Executive Capital held 8 positions worth $208M, up 4.8% from $199M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital deployed $34.9M of net new capital in Q4 2017, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Cardtronics plc Class A Ordinary Shares (UK): 1,945,655 shares worth $36M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 74% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was CIT Group Inc., an estimated $10.6M trimmed.

  • Hudson Executive Capital's largest Q4 2017 buy was Cardtronics plc Class A Ordinary Shares (UK): 1,945,655 shares worth $36M.
  • Hudson Executive Capital added most to Acorda Therapeutics in Q4 2017, an estimated $10M increase.
  • Hudson Executive Capital's biggest Q4 2017 reduction was CIT Group Inc., cutting an estimated $10.6M.
  • Hudson Executive Capital fully exited Magellan Health Services, Inc. in Q4 2017, selling an estimated $8.52M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $208M portfolio in Q4 2017.
  • Hudson Executive Capital opened 2 new positions and closed 1 in Q4 2017.
  • Hudson Executive Capital's portfolio value rose 4.8% quarter-over-quarter to $208M.

Based on Hudson Executive Capital's 13F filing for Q4 2017, filed 14 Feb 2018.